{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T18:27:54Z","timestamp":1792520874759,"version":"4.5.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2005,3,29]],"date-time":"2005-03-29T00:00:00Z","timestamp":1112054400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2005,4]]},"DOI":"10.1038\/sj.bjc.6602495","type":"journal-article","created":{"date-parts":[[2005,3,29]],"date-time":"2005-03-29T17:23:31Z","timestamp":1112117011000},"page":"1475-1485","source":"Crossref","is-referenced-by-count":53,"title":["Ascites induces modulation of \u03b16\u03b21 integrin and urokinase plasminogen activator receptor expression and associated functions in ovarian carcinoma"],"prefix":"10.1038","volume":"92","author":[{"given":"N","family":"Ahmed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Riley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Oliva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Rice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Quinn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2005,3,29]]},"reference":[{"key":"BF6602495_CR1","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1083\/jcb.147.1.89","volume":"147","author":"JA Aguirre Ghiso","year":"1999","unstructured":"Aguirre Ghiso JA, Kovalski K, Ossowski L (1999) Tumor dormancy induced by downregulation of urokinase receptor in human carcinoma involves integrin and MAPK signaling. J Cell Biol 147: 89\u2013104","journal-title":"J Cell Biol"},{"key":"BF6602495_CR2","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1038\/sj.onc.1205286","volume":"21","author":"N Ahmed","year":"2002","unstructured":"Ahmed N, Niu J, Dorahy DJ, Gu X, Andrews S, Meldrum CJ, Scott RJ, Baker MS, Macreadie IG, Agrez MV (2002a) Direct integrin alphavbeta6-ERK binding: implications for tumour growth. Oncogene 21: 1370\u20131380","journal-title":"Oncogene"},{"key":"BF6602495_CR3","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1038\/sj.bjc.6601098","volume":"89","author":"N Ahmed","year":"2003","unstructured":"Ahmed N, Oliva K, Wang Y, Quinn M, Rice G (2003a) Downregulation of urokinase plasminogen activator receptor expression inhibits Erk signalling with concomitant suppression of invasiveness due to loss of uPAR\u2013beta1 integrin complex in colon cancer cells. Br J Cancer 89: 374\u2013384","journal-title":"Br J Cancer"},{"key":"BF6602495_CR4","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1093\/carcin\/23.2.237","volume":"23","author":"N Ahmed","year":"2002","unstructured":"Ahmed N, Pansino F, Clyde R, Murthi P, Quinn MA, Rice GE, Agrez MV, Mok S, Baker MS (2002b) Overexpression of alphavbeta6 integrin in serous epithelial ovarian cancer regulates extracellular matrix degradation via the plasminogen activation cascade. Carcinogenesis 23: 237\u2013244","journal-title":"Carcinogenesis"},{"key":"BF6602495_CR5","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1002\/path.1441","volume":"201","author":"N Ahmed","year":"2003","unstructured":"Ahmed N, Riley C, Oliva K, Stutt E, Rice GE, Quinn MA (2003b) Integrin-linked kinase expression increases with ovarian tumour grade and is sustained by peritoneal tumour fluid. J Pathol 201: 229\u2013237","journal-title":"J Pathol"},{"key":"BF6602495_CR6","doi-asserted-by":"publisher","first-page":"6249","DOI":"10.1073\/pnas.96.11.6249","volume":"96","author":"N Auersperg","year":"1999","unstructured":"Auersperg N, Pan J, Grove BD, Peterson T, Fisher J, Maines-Bandiera S, Somasiri A, Roskelley CD (1999) E-cadherin induces mesenchymal-to-epithelial transition in human ovarian surface epithelium. Proc Natl Acad Sci USA 96: 6249\u20136254","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF6602495_CR7","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1002\/hep.1840220518","volume":"22","author":"NA Begum","year":"1995","unstructured":"Begum NA, Mori M, Matsumata T, Takenaka K, Sugimachi K, Barnard GF (1995) Differential display and integrin alpha 6 messenger RNA overexpression in hepatocellular carcinoma. Hepatology 22: 1447\u20131455","journal-title":"Hepatology"},{"key":"BF6602495_CR8","doi-asserted-by":"publisher","first-page":"4209","DOI":"10.1158\/0008-5472.CAN-04-0060","volume":"64","author":"D Bian","year":"2004","unstructured":"Bian D, Su S, Mahanivong C, Cheng RK, Hau Q, Pan ZK, Sun P, Haung S (2004) Lysophosphatidic acid stimulates ovarian cancer cell migration via a Ras-MEK kinase 1 pathway. Cancer Res 64: 4209\u20134217","journal-title":"Cancer Res"},{"key":"BF6602495_CR9","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1055\/s-0037-1615846","volume":"82","author":"F Blasi","year":"1999","unstructured":"Blasi F (1999) Proteolysis, cell adhesion, chemotaxis, and invasiveness are regulated by the u-PA-u-PAR-PAI-1 system. Thromb Haemost 82: 298\u2013304","journal-title":"Thromb Haemost"},{"key":"BF6602495_CR10","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1002\/ijc.2910540217","volume":"54","author":"C Bottini","year":"1993","unstructured":"Bottini C, Miotti S, Fiorucci S, Facheris P, Menard S, Colnaghi MI (1993) Polarization of the alpha 6 beta 4 integrin in ovarian carcinomas. Int J Cancer 54: 261\u2013267","journal-title":"Int J Cancer"},{"key":"BF6602495_CR11","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1006\/gyno.1998.5262","volume":"72","author":"F Carreiras","year":"1999","unstructured":"Carreiras F, Cruet S, Staedel C, Sichel F, Gauduchon P (1999a) Human ovarian adenocarcinoma cells synthesize vitronectin and use it to organize their adhesion. Gynecol Oncol 72: 312\u2013322","journal-title":"Gynecol Oncol"},{"key":"BF6602495_CR12","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1002\/(SICI)1097-0215(19990118)80:2<285::AID-IJC19>3.0.CO;2-L","volume":"80","author":"F Carreiras","year":"1999","unstructured":"Carreiras F, Rigot V, Cruet S, Andre F, Gauduchon P, Marvaldi J (1999b) Migration properties of the human ovarian adenocarcinoma cell line IGROV1: importance of alpha(v)beta3 integrins and vitronectin. Int J Cancer 80: 285\u2013294","journal-title":"Int J Cancer"},{"key":"BF6602495_CR13","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1023\/A:1026519016213","volume":"18","author":"RC Casey","year":"2000","unstructured":"Casey RC, Skubitz AP (2000) CD44 and beta1 integrins mediate ovarian carcinoma cell migration toward extracellular matrix proteins. Clin Exp Metast 18: 67\u201375","journal-title":"Clin Exp Metast"},{"key":"BF6602495_CR14","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1126\/science.7716514","volume":"268","author":"EA Clark","year":"1995","unstructured":"Clark EA, Brugge JS (1995) Integrins and signal transduction pathways: the road taken. Science 268: 233\u2013239","journal-title":"Science"},{"key":"BF6602495_CR15","volume-title":"SPSS for Windows-Analysis Without Anguish","author":"SJ Coakes","year":"1996","unstructured":"Coakes SJ, Steed LG (1996) SPSS for Windows-Analysis Without Anguish. Sydney: Wiley"},{"key":"BF6602495_CR16","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1002\/jcb.10675","volume":"91","author":"MC Demetriou","year":"2004","unstructured":"Demetriou MC, Cress AE (2004) Integrin clipping: a novel adhesion switch? J Cell Biochem 91: 26\u201335","journal-title":"J Cell Biochem"},{"key":"BF6602495_CR17","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.yexcr.2003.11.023","volume":"294","author":"MC Demetriou","year":"2004","unstructured":"Demetriou MC, Pennington ME, Nagle RB, Cress AE (2004) Extracellular alpha 6 integrin cleavage by urokinase-type plasminogen activator in human prostate cancer. Expt Cell Res 294: 550\u2013558","journal-title":"Expt Cell Res"},{"key":"BF6602495_CR18","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1046\/j.1432-0436.2002.700904.x","volume":"70","author":"IJ Fidler","year":"2002","unstructured":"Fidler IJ (2002) The organ microenvironment and cancer metastasis. Differentiation 70: 498\u2013505","journal-title":"Differentiation"},{"key":"BF6602495_CR19","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/0014-4827(92)90272-A","volume":"201","author":"M Gomez","year":"1992","unstructured":"Gomez M, Navarro P, Quintanilla M, Cano A (1992) Expression of alpha 6 beta 4 integrin increases during malignant conversion of mouse epidermal keratinocytes: association of beta 4 subunit to the cytokeratin fraction. Exp Cell Res 201: 250\u2013261","journal-title":"Exp Cell Res"},{"key":"BF6602495_CR20","doi-asserted-by":"publisher","first-page":"7045","DOI":"10.1158\/0008-5472.CAN-04-1800","volume":"64","author":"LE Graves","year":"2004","unstructured":"Graves LE, Ariztia EV, Navari JR, Matzel HJ, Stack MS, Fishman DA (2004) Proinvasive properties of ovarian cancer ascites-derived veshicles. Cancer Res 64: 7045\u20137049","journal-title":"Cancer Res"},{"key":"BF6602495_CR21","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/S1470-2045(02)00716-7","volume":"3","author":"M Greaves","year":"2002","unstructured":"Greaves M, Greaves MF (2002) Cancer causation: the Darwinian downside of past success? Evolution, immune response, and cancer. Lancet Oncol 3: 244\u2013251","journal-title":"Lancet Oncol"},{"key":"BF6602495_CR22","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/0002-9378(70)90031-1","volume":"106","author":"K Hirabayashi","year":"1970","unstructured":"Hirabayashi K, Graham J (1970) Genesis of ascites in ovarian cancer. Am J Obstet Gynecol 106: 492\u2013497","journal-title":"Am J Obstet Gynecol"},{"key":"BF6602495_CR23","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/0092-8674(92)90115-S","volume":"69","author":"RO Hynes","year":"1992","unstructured":"Hynes RO (1992) Integrins: versatility, modulation, and signaling in cell adhesion. Cell 69: 11\u201325","journal-title":"Cell"},{"key":"BF6602495_CR24","first-page":"1743","volume":"7","author":"G Konecny","year":"2001","unstructured":"Konecny G, Untch M, Pihan A, Kimmig R, Gropp M, Stieber P, Hepp H, Slamon D, Pegram M (2001) Association of urokinase-type plasminogen activator and its inhibitor with disease progression and prognosis in ovarian cancer. Clin Cancer Res 7: 1743\u20131749","journal-title":"Clin Cancer Res"},{"key":"BF6602495_CR25","doi-asserted-by":"publisher","first-page":"2563","DOI":"10.1038\/sj.onc.1201098","volume":"14","author":"E Lengyel","year":"1997","unstructured":"Lengyel E, Wang H, Gum R, Simon C, Wang Y, Boyd D (1997) Elevated urokinase-type plasminogen activator receptor expression in a colon cancer cell line is due to a constitutively activated extracellular signal-regulated kinase-1-dependent signaling cascade. Oncogene 14: 2563\u20132573","journal-title":"Oncogene"},{"key":"BF6602495_CR26","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1016\/S0002-9440(10)65406-5","volume":"154","author":"K Lessan","year":"1999","unstructured":"Lessan K, Aguiar DJ, Oegema T, Siebenson L, Skubitz AP (1999) CD44 and beta1 integrin mediate ovarian carcinoma cell adhesion to peritoneal mesothelial cells. Am J Pathol 154: 1525\u20131537","journal-title":"Am J Pathol"},{"key":"BF6602495_CR27","first-page":"2950","volume":"53","author":"CS Lin","year":"1993","unstructured":"Lin CS, Zhang K, Kramer R (1993) Alpha 6 integrin is up-regulated in step increments accompanying neoplastic transformation and tumorigenic conversion of human fibroblasts. Cancer Res 53: 2950\u20132953","journal-title":"Cancer Res"},{"key":"BF6602495_CR28","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1083\/jcb.135.6.1633","volume":"135","author":"S Miyamoto","year":"1996","unstructured":"Miyamoto S, Teramoto H, Gutkind JS, Yamada KM (1996) Integrins can collaborate with growth factors for phosphorylation of receptor tyrosine kinases and MAP kinase activation: roles of integrin aggregation and occupancy of receptors. J Cell Biol 135: 1633\u20131642","journal-title":"J Cell Biol"},{"key":"BF6602495_CR29","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1097\/00008390-199303000-00247","volume":"3","author":"R Mortarini","year":"1993","unstructured":"Mortarini R, Anichini A (1993) From adhesion to signalling: roles of integrins in the biology of human melanoma. Melanoma Res 3: 87\u201397","journal-title":"Melanoma Res"},{"key":"BF6602495_CR30","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1006\/cyto.1995.0073","volume":"7","author":"FA Offner","year":"1995","unstructured":"Offner FA, Obrist P, Stadlmann S, Feichtinger H, Klingler P, Herold M, Zwierzina H, Hittmair A, Mikuz G, Abendstein B, Zeimet A, Marth C (1995) IL-6 secretion by human peritoneal mesothelial and ovarian cancer cells. Cytokine 7: 542\u2013547","journal-title":"Cytokine"},{"key":"BF6602495_CR31","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.1172\/JCI116817","volume":"92","author":"N Pedersen","year":"1993","unstructured":"Pedersen N, Schmitt M, Ronne E, Nicoletti MI, Hoyer-Hansen G, Conese M, Giavazzi R, Dano K, Kuhn W, Janicke F, Blasi F (1993) A ligand-free, soluble urokinase receptor is present in the ascitic fluid from patients with ovarian cancer. J Clin Invest 92: 2160\u20132167","journal-title":"J Clin Invest"},{"key":"BF6602495_CR32","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1006\/gyno.2002.6760","volume":"86","author":"M Richardson","year":"2002","unstructured":"Richardson M, Gunawan J, Hatton MW, Seidlitz E, Hirte HW, Singh G (2002) Malignant ascites fluid (MAF), including ovarian-cancer-associated MAF, contains angiostatin and other factor(s) which inhibit angiogenesis. Gynecol Oncol 86: 279\u2013287","journal-title":"Gynecol Oncol"},{"key":"BF6602495_CR33","first-page":"397","volume":"8","author":"G Sandmann","year":"2003","unstructured":"Sandmann G, Siess W, Essler M (2003) Lysophosphatidic acid is the unique platelet-activating substance in human malignant ascites. Eur J Med Res 8: 397\u2013404","journal-title":"Eur J Med Res"},{"key":"BF6602495_CR34","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1038\/10533","volume":"5","author":"JS Sebolt-Leopold","year":"1999","unstructured":"Sebolt-Leopold JS, Dudley DT, Herrera R, Van Becelaere K, Wiland A, Gowan RC, Tecle H, Barrett SD, Bridges A, Przybranowski S, Leopold WR, Saltiel AR (1999) Blockade of the MAP kinase pathway suppresses growth of colon tumors in vivo. Nat Med 5: 810\u2013816","journal-title":"Nat Med"},{"key":"BF6602495_CR35","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1097\/00004347-200001000-00003","volume":"19","author":"S Silverberg","year":"2000","unstructured":"Silverberg S (2000) Histopathologic grading of ovarian carcinoma: a review and proposal. Int J Gynecol Pathol 19: 7\u201315","journal-title":"Int J Gynecol Pathol"},{"key":"BF6602495_CR36","first-page":"305","volume":"107","author":"AP Skubitz","year":"2002","unstructured":"Skubitz AP (2002) Adhesion molecules. Cancer Treat Res 107: 305\u2013329","journal-title":"Cancer Treat Res"},{"key":"BF6602495_CR37","first-page":"1445","volume":"148","author":"AP Skubitz","year":"1996","unstructured":"Skubitz AP, Bast Jr RC, Wayner EA, Letourneau PC, Wilke MS, Bartolazzi A, Kaczmarek J, Nicolo G, Risso AM, Tarone G, Rossino P, Defilippi P, Castellani P (1996) Expression of alpha 6 and beta 4 integrins in serous ovarian carcinoma correlates with expression of the basement membrane protein laminin. Localization of the alpha 3 beta 1 integrin in some common epithelial tumors of the ovary and in normal equivalents. Am J Pathol 148: 1445\u20131461","journal-title":"Am J Pathol"},{"key":"BF6602495_CR38","first-page":"1228","volume":"57","author":"T Strobel","year":"1997","unstructured":"Strobel T, Swanson L, Cannistra SA (1997) In vivo inhibition of CD44 limits intra-abdominal spread of a human ovarian cancer xenograft in nude mice: a novel role for CD44 in the process of peritoneal implantation. Cancer Res 57: 1228\u20131232","journal-title":"Cancer Res"},{"key":"BF6602495_CR39","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1046\/j.1525-1438.2000.010005372.x","volume":"10","author":"C Tecimer","year":"2000","unstructured":"Tecimer C, Doering DL, Goldsmith LJ, Meyer JS, Abdulhay G, Wittliff JL (2000) Clinical relevance of urokinase-type plasminogen activator, its receptor and inhibitor type 1 in ovarian cancer. Int J Gynecol Cancer 10: 372\u2013381","journal-title":"Int J Gynecol Cancer"},{"key":"BF6602495_CR40","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/S0303-7207(03)00067-4","volume":"202","author":"Y Ueoka","year":"2003","unstructured":"Ueoka Y, Kato K, Wake N (2003) Hepatocyte growth factor modulates motility and invasiveness of ovarian carcinomas via ras mediated pathway. Mol Cell Endocrinol 202: 81\u201388","journal-title":"Mol Cell Endocrinol"},{"key":"BF6602495_CR41","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/S0002-9440(10)61773-7","volume":"159","author":"G van der Pluijm","year":"2001","unstructured":"van der Pluijm G, Sijmons B, Vloedgraven H, van der Bent C, Drijfhout JW, Verheijen J, Quax P, Karperien M, Papapoulos S, Lowik C (2001) Urokinase-receptor\/integrin complexes are functionally involved in adhesion and progression of human breast cancer in vivo. Am J Pathol 159: 971\u2013982","journal-title":"Am J Pathol"},{"key":"BF6602495_CR42","first-page":"5434","volume":"55","author":"C Van Waes","year":"1995","unstructured":"Van Waes C, Surh DM, Chen Z, Kirby M, Rhim JS, Brager R, Sessions RB, Poore J, Wolf GT, Carey TE (1995) Increase in suprabasilar integrin adhesion molecule expression in human epidermal neoplasms accompanies increased proliferation occurring with immortalization and tumor progression. Cancer Res 55: 5434\u20135444","journal-title":"Cancer Res"},{"key":"BF6602495_CR43","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1083\/jcb.144.6.1285","volume":"144","author":"Y Wei","year":"1999","unstructured":"Wei Y, Yang X, Liu Q, Wilkins JA, Chapman HA (1999) A role for caveolin and the urokinase receptor in integrin-mediated adhesion and signaling. J Cell Biol 144: 1285\u20131294","journal-title":"J Cell Biol"},{"key":"BF6602495_CR44","first-page":"89","volume":"10","author":"H Yabushita","year":"2003","unstructured":"Yabushita H, Shimazu M, Noguchi M, Kishida T, Narumiya H, Sawaguchi K (2003) Vascular endothelial growth factor activating matrix metalloproteinase in ascitic fluid during peritoneal dissemination of ovarian cancer. Oncol Rep 10: 89\u201395","journal-title":"Oncol Rep"},{"key":"BF6602495_CR45","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/s10434-999-0373-0","volume":"6","author":"BK Zebrowski","year":"1999","unstructured":"Zebrowski BK, Liu W, Ramirez K, Akagi Y, Mills GB, Ellis LM (1999) Markedly elevated levels of vascular endothelial growth factor in malignant ascites. Ann Surg Oncol 6: 373\u2013378","journal-title":"Ann Surg Oncol"},{"key":"BF6602495_CR46","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1200\/JCO.1998.16.5.1861","volume":"16","author":"AG Zeimet","year":"1998","unstructured":"Zeimet AG, Widschwendter M, Knabbe C, Fuchs D, Herold M, Muller-Holzner E, Daxenbichler G, Offner FA, Dapunt O, Marth C (1998) Ascitic interleukin-12 is an independent prognostic factor in ovarian cancer. J Clin Oncol 16: 1861\u20131868","journal-title":"J Clin Oncol"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/6602495.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6602495","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6602495.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T12:15:46Z","timestamp":1684412146000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/6602495"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,3,29]]},"references-count":46,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2005,4]]}},"alternative-id":["BF6602495"],"URL":"https:\/\/doi.org\/10.1038\/sj.bjc.6602495","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,3,29]]}}}